1. Pre-sales were up 40% YoY - ₹2608 Cr. Highest in the last 12 quarters. 2. Affordable and mid-income segment accounted for 63% sales.
3. The UK pre-sales were also the best ever quarterly performance(GSQ -£177m, LSQ - £14mn ). 4. There was no major impact on construction progress from Omicron. There has been a slight deferment of sales(~₹200 Cr) which is expected to come back.
5. Raised ₹4000 Cr through a QIP with participation from marquee global investors. The proceeds were used to acquire new land through JD/JVA, buying out of minority interest in Palava and ₹750 Cr was used to take the benefit of 50%
rebate by paying various regulatory fees in advance. The benefit from this is estimated to be around ₹600 Cr. 6. Another benefit from this is that the regulatory costs for various projects have been frontloaded and as sales revenues start to come in, it will
mostly contribute to increasing OCF. They still have a surplus of ~₹2200 Cr left from the QIP proceeds, which will be used for growth through the capital light JDA model over next 5-6 quarters.
7. Added 11 JDA projects this financial year amounting to cumulative GDV of ~₹14,600 Cr. Of this, 6 projects were added this quarter.
They are seeing an appropriate level of price increase compared to the increase in price of construction materials.
Selling prices are increasing by 5% on average across all segments. It is expected to increase by 6% in the future. 8. Inflation affects their business in 2 ways - cost of materials go up and mortgage rates go up.
Management does not expect much softening of demand due to increase in interest rates. The cost of materials as a percentage of sales price is the lowest in India at around 30%. So the company does not foresee any big issues with the increase of raw material cost.
9. The positive of this is that the company has a lot of finished inventory already built up. So as selling prices go up, margins are expected to increase. 10. The interest cost for Q4 is expected to be around ₹300 Cr. They are targeting ₹800 Cr interest cost for FY23.
11. The management has indicated the the entire UK surplus cash will be repatriated to India in next 5-6 quarters 12. The net debt has been reduced to ₹9896 Cr. The guidance for FY22 was that net debt will be below ₹10,000 Cr which has been achieved ahead of schedule.
They reduced ₹400 Cr of debt through OCF only. 13. They are seeing a lot of interest in the Palava Ecosystem from commercial players. A global sportswear player is going to be setting up their logistics hub spread over 1 mn sq ft area.
A hospital chain is buying land to set up a 100 bed hospital. A pharma company is buying land to set up an R&D facility. They are also in talks with a marquee ecommerce player to set up a facility there.
14. They have 3 main segments - Affordable, Aspirational and Premium. They are seeing very strong growth across all segments and all geographies. Conversion rates have been the best in Affordable and Premium segments.
15. In Q3 FY22 they had 27,000 consumers come to their site in 13 weeks. That is an average of 2,000 walk-ins every week. That is an improvement of 10% YoY. The conversion rate was about 9%. This is the highest it has been in the last 20 quarters.
16. They have planned their JV/JDA in such a way that it gives them access to markets in which they currently do not have a presence in. They are not present in markets surrounding Mumbai (like Navi Mumbai). The JVs will help them access those markets.
17. They are focusing on replenishing supply in markets where inventory is sold out. In the South & Central Mumbai market, projects in Kalachowki and Near KEM Hospital are fully sold out. They are looking to replace that supply around the same price range of
about ₹23,000-₹25,000 per sq. ft 18. Due to the profit share model, as the final selling price of the unit increases the value of the land will implicitly increase as well.
19. They are looking to invest in Digital Infrastructure in Palava. Land value will increase as Digital Infrastructure improves there.
20. 3 projects to be launched in South Mumbai - Walkeshwar(Malabar Hill) to be launched Q4 FY22, Tardeo expected to launch in Q2 FY23 and the Prabhadevi project is not envisaged to launch in FY23.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#TorrentPharma Q3 FY22 concall highlights
💊
Like and retweet for better reach !
1. Revenues were ₹2108 Cr (6% growth YoY), EBITDA was ₹585 Cr (5% decline YoY), PAT was ₹249 Cr (16% decline YoY).
2. Profitability was affected due to higher than anticipated price erosion in the US market and under absorption of certain amounts of plant overheads.
They have rolled out cost optimization initiatives and are confident of reviving the margins in a short period of time.
3. The Board has recommended an interim dividend of ₹25 per share. 4. India business revenues were at ₹1072 Cr (15% growth).Growth was driven by top brands in all their focus therapies. Of the 15% growth, volume accounts for 4%, price for 8% and new products account for 3%
1. Consolidated Revenue from operations for Q3 was ₹188 Cr, growth of 8% YOY. 2. Deferred revenue in Q3 was ₹790 Cr, up 25% YOY.
3. Consolidated EBITDA was ₹79 Cr, representing a margin of 42%.
Net Profit for Q3 was ₹ 70 Cr, with a margin of 33%.
Cash Generated from Operating Activities ₹ 84 Cr, up 9% YOY.
As of December 31, 2021, total cash and investment balance was at ₹ 2,523 Cr.
Business Update
1. During the quarter, the company added 5,833 paying subscribers, closing the total count at approximately 156,000. 2. Unique business inquiries is stood at 23 million 3. Average matchmaking for unique business inquiry reduced to 5.3x as against 6.3x
1. Total revenue ₹102.32Cr for Q3 as compared to ₹88.08Cr in Q2. 2. Adjusted EBITDA Margins for the quarter was 32%, 30% YOY growth. 3. Loss before tax in Q3 was ₹-22.41Cr
4. Loss after tax was ₹-18.48Cr.
Business Update.
1. Company's 9M revenue was impacted because of Covid & Semiconductor shortage.
But the company has grown despite the car market de-growth. 2. Shriram Automall listing touch All time high of 1.3Mn.
3. Company had 31 mn Average Monthly Unique Visitors in Q3. 4. 86.20% Organic Unique Visitors in Q3. 5. Company had exceptional and non-recurring, non-cash adjustment of Rs. 140 crores for ESOP granted in FY21.
1. Net sales were up 34% YoY. Gross margins were up 220 bps at 57%. 2. Price hikes were taken to compensate for increase in raw material costs.
3. EBITDA margins were up 510 bps at 27.2% due to price increases, superior product mix and cost optimization. 4. MDF sales grew by 40.2% ₹356.4 Cr and contributed 84% of the topline.
5. MDF volumes fell by 2.4%. MDF domestic revenues were ₹307.35 Cr whereas exports contributed ₹43.05 Cr. Domestic realizations are up by 42.6% and export realizations are up by 49%.
6. The Uttarakhand MDF plant remained inoperative for nearly half the
1. Revenues grew by 78.2% you from ₹494 Cr to ₹880 Cr in Q3FY22 2. EBITDA margin expanded by 220 bps YoY to 22.8% in Q3 FY22
driven by economies of scale , effective cost management marginally settled off by higher freight cost.
3.Strong volume growth, high realisation and better product mix 4. Revenue growth YoY- Europe -124% , NAFTA-76% , LATAM-18 % , RoW 19% 5. Geographies wise gross margins
6. Europe- 36%, NAFTA 37%, LATAM 14%, ROW 23%
Segmental review
1. Agrochemicals : Non-Agrochemicals revenue mix stood at 82:18 in Q3 FY22 as against 81:19 in Q3 FY21 2. Agrochemicals revenues during Q3 FY22 grew by 79.8% YoY
1. 60%-70% of the Tips library is 90’s Music
2.The Content charge for the quarter was around ₹10 cr 3. Overall the Viewership was reduced due
to opening up of the lockdown, but had no direct effect on Tips business. 4. When Tips came up with their IPO in the year 2000 they acquired 12 Labels at once like Times music, Gold Theatre and also a western
5. As always content cost is written off in the same year of acquiring the content. They do lumpsum deals with singer instead of royalty model